ChartWise customers see strong revenue improvement because the vendor is attuned to their needs and because the vendor’s proactive, nimble support helps customers fully leverage and optimize the solution,” the research firm added.

Lumere is a software subscription service that aggregates all of the most important health care studies, on new medical devices and medications in particular, and distills the information into a sort of medical shorthand for the time-pressed doctor or hospital administrator.

Our ProviderTrust team is so excited to be honored for the third consecutive year on the 2018 Inc. 5000 list as one of the fastest-growing private companies in America. Only 1 in 4 companies have continued to make the list three times, showcasing our continued growth, focus, and service to our customers. We are always challenging ourselves to be engaged in the healthcare community, and are driven by providing simple solutions for compliance and HR professionals. 

For insurtech companies offering health insurance and employee benefit quoting functionality, the Multi-Line Rating API provides a single point of access to plan availability, benefits and rates for multiple lines of coverage. This eliminates the substantial engineering otherwise required to accurately rate and present these products.

“Vericred’s new provider network analytics suite offers a graphical, 360 degree view of a carrier’s own networks and those of their competitors,” said Michael W. Levin, Vericred’s co-founder and CEO. “Networks, broad and narrow, are a key health insurance product differentiator. Our network analytics suite, developed based on feedback from carrier partners, helps carriers identify competitive advantages and weaknesses and to curate their networks to strengthen their product offerings.”

Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, today announced that the private equity team at NovaQuest Capital Management, L.L.C. ("NovaQuest") has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital. The deep clinical, operational, and financial resources of NovaQuest will allow Clinical Ink to aggressively pursue growth opportunities and fuel investment in new products and operational capabilities.